Try our beta test site

CCR5-blockade in Metastatic Colorectal Cancer (MARACON)

This study has been completed.
Sponsor:
Collaborator:
University Hospital Heidelberg
Information provided by (Responsible Party):
National Center for Tumor Diseases, Heidelberg
ClinicalTrials.gov Identifier:
NCT01736813
First received: October 24, 2012
Last updated: March 20, 2017
Last verified: July 2014